Ketamine improves survival in severe burn injury in rats via the expression of heat shock protein 70, far or close to the clinical perspective?
Abstract
The purpose of this reflection or commentary is not to demerit the efforts of the researchers, but rather to highlight some aspects that should be taken into account in the future for implementing experimental designs that may potentially contribute to strengthen the links between basic biomedical and clinical research, referring to the research article entitled Ketamine improves survival in severe burn injury in rats via the Expression of Heat Shock Protein 70. This is a purely constructive reflection aimed at encouraging those who are one way or other involved in research, to develop a more comprehensive analysis and a proposal for an experimental design that enables the extrapolation of the results from animal models to a clinical application, with a limited number of subjects but preserving the validity of the trial, in addition to making the best possible use of the experimental subjects and of the relationship between basic and clinical research. In fact, the ethical guidelines issued by the Councilfor International Organizations of Medical Sciences, in its chapter on animal experiments emphasize that the validity of a trial allows for using the minimum number of animals in an experiment. The article that makes reference to this matter was published by Zhang Meng-yuan et al., and concludes that Ketamine therapy improves the survival of patients with severe burn injuries via the expression of heat shock proteins in the heart and the brain.
References
2. Howland RH. Ketamin for the treatment of depression. J Psychosoc Nurs Ment Health Serv. 2013;51:11-4.
3. Murrough JW. Ketamine as a novel antidepressant: From synapse to behavior. Clin Pharmacol Ther. 2012;91: 303-9.
4. Zarate CA Jr, Mathews D, Ibrahim L, Chaves JF, Marquardt C, Ukoh I, et al. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63:856-64.
5. Murrough JW, Perez AM, Pillemer S, Stern J, Pandes MK, aan het Rot M, et al. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry. 2013;74:250-6. D0I:./j.biopsych.-L022.
6. Jat KR, Chawla D. Ketamine for management of acute exacerbations of asthma in children. Cochrane Database of Systematic Reviews. 2012;11:1-20.
7. Neder Meyer T, Lázaro da Silva A. Ketamine reduces mortality of severely burnt rats, when compared to midazolam plus fentanyl. Burns. 2004;30:425-30.
8. Norambuena C, Yañez J, Flores V, Puentes P, Carrasco P, Villena R. Oral ketamine and midazolam for pediatric burn patients: A prospective, randomized, double-blind study. J Pediatr Surg. 2013;48:629-34.
9. Kundra P, Velayudhan S, Krishnamachari S, Gupta SL. Oral ketamine and dexmedetomidine in adults' burns wound dressing-A randomized double blind cross over study. Burns. 2013;39:1150-6, 3.
10. Reich DL, Silvay G. Ketamine: An update on the first twenty-five years of clinical experience. Can J Anaesth. 1989;36:186-97.
11. Meng-yuan Z, Gong-ming W, Fang-lin L, Ling D, Yan-bing X, Joseph-S C. La ketamina mejora la sobrevida en lesión por quemadura severa en ratas, a través de la expresión de la proteína de choque 70. Rev Colomb Anestesiol. 2013;41:82-7.
12. Murshid A, Eguchi T, Calderwood SK. Stress proteins in aging and life span. Int J Hyperthermia. 2013;29:442-7.
13. Feng PM, Chen W, Lin H, Chou KC. iHSP-PseRAAAC: Identifying the heat shock protein families using pseudo reduced amino acid alphabet composition. Anal Biochem. 2013;442:118-25.
14. Vidal Magalhaes W, Gouveia Nogueira MF, Kaneko TM. Heat shock proteins (HSP): Dermatological implications F perspectives. Eur J Dermatol. 2012;22:8-13.
15. Richter K, Haslbeck M, Buchner J. The heat shock response: Life on the verge of death. Mol Cell. 2010;40:253-66.
16. Van Noort JM, Bsibsi M, Nacken P, Gerritsen WH, Amor S. The link between small heat shock proteins and the immune system. Int J Biochem Cell Biol. 2012;44:1670-9.
17. Murphy ME. The HSP70 family and cancer. Carcinogenesis. 2013;34:1181-8.
18. White DJ, Carlson D, Ordway GA, Horton JW. Protective role of heat stress in burn trauma. Crit Care Med. 2004;32:1338-45.
19. Rodeberg DA, Meyer JG, Babcock GF. Heat shock response: Presence and effects in burn patient neutrophils. J Leukoc Biol. 1999;66:773-80.
20. Carr VM, Farbman AL. Effect of ketamine on stress protein immunoreactivities in rat olfactory mucosa. J Psychosoc Nurs Ment Health Serv Neuro Report. 1993;5:197-200.
21. Xiao H, Xu HW, Liu H, Zhang L. Effect of ketamine on endotoxin-induced septic shock in rats and its mechanism. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007;19:303-5.
22. Liao R, Wang QY, Zhang L, Xiao H. Expression of HSP70 induced by ketamine in the hippocampus of rat at different ages. Sichuan Da Xue Xue Bao Yi Xue Ban. 2004;35:492-5.
23. Gurfinkel R, Czeiger D, Douvdevani A, Shapira Y, Artru AA, Sufaro Y, et al. Ketamine improves survival in burn injury followed by sepsis in rats. Anesth Analg. 2006;103:396-402.
24. Howard-Jones NA. CIOMS ethical code for animal experimentation. WHO Chronicle. 1985;39:51-6.
25. McGuinness SK, Wasiak J, Cleland H, Symons J, Hogan L, Hucker T, et al. A systematic review of ketamine as an analgesic agent in adult burn injuries. Pain Med. 2011;12:1551-8.
Downloads
Altmetric
Article metrics | |
---|---|
Abstract views | |
Galley vies | |
PDF Views | |
HTML views | |
Other views |